BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Focus Surgery Inc. To Exhibit The Sonablate(R) 500 V4 System - The Choice For HIFU - At The Annual AUA Conference In Atlanta, GA


5/16/2006 10:45:14 AM

INDIANAPOLIS, May 16 /PRNewswire/ -- Focus Surgery, Inc. will exhibit the Sonablate(R) 500 HIFU system, that is used worldwide for the treatment of localized prostate cancer, at the upcoming American Urology Association (AUA) meeting May 20-23, 2006, in Atlanta, GA. The AUA's Annual Meeting is the largest meeting of urologic professionals in the world gathering more than 10,000 urologists and healthcare professionals and 5,000 exhibitors. These urologists are dedicated to advancing urological treatment, increasing standards of care, promoting research and fostering new technology.

"We are pleased to present the new enhancements for the Sonablate(R) 500, the fastest-growing and most advanced HIFU technology in the world. Focus Surgery is the pioneer in the field of HIFU (High Intensity Focused Ultrasound) and continues to lead the way in the development of HIFU technology. We are grateful to National Cancer Institute of National Institutes of Health for providing the research funding for these advanced developments," said Narendra T. Sanghvi, CEO and President of Focus Surgery. "Globally, the Sonablate(R) 500 is the most widely accepted HIFU system because it meets physician clinical requirements while providing an effective, safe, and minimally invasive therapy option to localized prostate cancer patients."

"Version 4 is great; our preliminary results are encouraging to me because the PSA and post-HIFU biopsy show great findings," says Dr. Toyoaki Uchida, M.D., Professor, Department of Urology, Tokai University Hachioji Hospital, Toyko, Japan.

"The Sonablate(R) 500 upgrade Version 4 software is superb and provides simultaneously both sagittal and transverse image stacks to plan accurate HIFU treatment from the base to apex with ease with higher level of safety," says Prof. Ami Sidi, Associate Professor and Chairman, Department of Urologic Surgery, Tel Aviv University, Israel.

V4 System Enhancements of the Sonablate(R) 500 that will be featured at the AUA focus on placing control of the treatment in the hands of the physician. These enhancements add advanced features including Wide Angle Treatment, Accurate RIM(TM), Point by Point Rectal Wall Distance, 2D and 3D (Volume) Stacks, Energy Delivery Measure, NVB Localization, and Power Control for Visual Feedback. As a result of these enhancements, the treatment time is reduced by 40 percent in most cases. All these enhancements increase treatment efficacy and safety by allowing additional physician control and visual feedback of the HIFU procedure.

Focus Surgery, Inc.

CONTACT: Megan Porter, Marketing Coordinator of Focus Surgery, Inc.,+1-317-541-1580


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->